Franck Laurent Brebion

Title: Franck Laurent Brebion: Innovator in Pharmaceutical Compounds

Introduction

Franck Laurent Brebion is a notable inventor based in Romainville, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target inflammatory conditions and cartilage degradation. With a total of 6 patents to his name, Brebion's work is recognized for its potential impact on treating osteoarthritis.

Latest Patents

One of Brebion's latest patents involves the development of 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis. This invention discloses compounds according to a specific formula, wherein various components are defined. The invention relates to compounds that inhibit ADAMTS, methods for their production, and pharmaceutical compositions that include these compounds. The methods of treatment aim to prevent or treat inflammatory conditions and diseases that involve the degradation of cartilage and disruption of cartilage homeostasis.

Career Highlights

Throughout his career, Franck Laurent Brebion has worked with prominent companies in the pharmaceutical industry. Notable among these are Galapagos NV and Les Laboratoires Servier. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Brebion has collaborated with several professionals in his field, including Luke Jonathan Alvey and David Amantini. These collaborations have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Franck Laurent Brebion is a distinguished inventor whose work in pharmaceutical compounds has the potential to significantly improve treatments for osteoarthritis and related conditions. His contributions to the field are marked by a commitment to innovation and collaboration.